Literature DB >> 1324919

Affinity-purified c-Jun amino-terminal protein kinase requires serine/threonine phosphorylation for activity.

V Adler1, A Polotskaya, F Wagner, A S Kraft.   

Abstract

The addition of phorbol esters to U937 leukemic cells stimulates the phosphorylation of c-Jun on serines 63 and 73. To isolate the protein kinase which stimulates this phosphorylation, we have used heparin-Sepharose chromatography followed by affinity chromatography over glutathione-Sepharose beads bound with a fusion protein of glutathione S-transferase and amino acids 5-89 of c-Jun (GST-c-Jun). Using this procedure we purify a 67-kDa protein which is capable of phosphorylating GST-c-Jun as well as the complete c-Jun protein. By making mutations in serines 63 and 73 and then creating a fusion protein with GST (GST-c-Jun mut), we demonstrate that this protein kinase specifically phosphorylates these sites in the c-Jun amino terminus. Treatment of purified c-Jun amino-terminal protein kinase (cJAT-PK) with phosphatase 2A inhibits its ability to phosphorylate GST-c-Jun. This inactivated enzyme can be reactivated by phosphorylation with protein kinase C (PKC), although PKC is not capable of phosphorylating the GST-c-Jun substrate. Because v-Jun cannot be phosphorylated in vivo, we compared the ability of cJAT-PK to bind to GST-v-Jun or GST-c-Jun mut. The cJAT-PK bound 50-fold better to GST-c-Jun mut than GST-v-Jun suggesting that the delta domain which is missing in v-Jun plays a role in binding the cJAT-PK. These results suggest that there is a protein kinase cascade mediated by protein phosphatases and PKC which regulates c-Jun phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1324919

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  The mammalian mitogen activated protein kinase network.

Authors:  P Lenormand
Journal:  Clin Mol Pathol       Date:  1995-12

2.  Selective interaction of JNK protein kinase isoforms with transcription factors.

Authors:  S Gupta; T Barrett; A J Whitmarsh; J Cavanagh; H K Sluss; B Dérijard; R J Davis
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

Review 3.  c-Jun, at the crossroad of the signaling network.

Authors:  Qinghang Meng; Ying Xia
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

4.  Direct interaction and N-terminal phosphorylation of c-Jun by c-Mil/Raf.

Authors:  G Radziwill; M Niehof; C Rommel; K Moelling
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Quantitative phosphoproteomics in nuclei of vasopressin-sensitive renal collecting duct cells.

Authors:  Steven J Bolger; Patricia A Gonzales Hurtado; Jason D Hoffert; Fahad Saeed; Trairak Pisitkun; Mark A Knepper
Journal:  Am J Physiol Cell Physiol       Date:  2012-09-19       Impact factor: 4.249

6.  MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6.

Authors:  L A Tibbles; Y L Ing; F Kiefer; J Chan; N Iscove; J R Woodgett; N J Lassam
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

7.  Signal transduction by tumor necrosis factor mediated by JNK protein kinases.

Authors:  H K Sluss; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 8.  Vasopressin and the regulation of aquaporin-2.

Authors:  Justin L L Wilson; Carlos A Miranda; Mark A Knepper
Journal:  Clin Exp Nephrol       Date:  2013-04-13       Impact factor: 2.801

9.  A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum.

Authors:  J A Frost; T D Geppert; M H Cobb; J R Feramisco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  In vitro association between the Jun protein family and the general transcription factors, TBP and TFIIB.

Authors:  C C Franklin; A V McCulloch; A S Kraft
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.